title: Insulin resistance and cancer: the role of insulin and IGFs.
abstract: Insulin, IGF1, and IGF2 are the most studied insulin-like peptides (ILPs). These are evolutionary conserved factors well known as key regulators of energy metabolism and growth, with crucial roles in insulin resistance-related metabolic disorders such as obesity, diseases like type 2 diabetes mellitus, as well as associated immune deregulations. A growing body of evidence suggests that insulin and IGF1 receptors mediate their effects on regulating cell proliferation, differentiation, apoptosis, glucose transport, and energy metabolism by signaling downstream through insulin receptor substrate molecules and thus play a pivotal role in cell fate determination. Despite the emerging evidence from epidemiological studies on the possible relationship between insulin resistance and cancer, our understanding on the cellular and molecular mechanisms that might account for this relationship remains incompletely understood. The involvement of IGFs in carcinogenesis is attributed to their role in linking high energy intake, increased cell proliferation, and suppression of apoptosis to cancer risks, which has been proposed as the key mechanism bridging insulin resistance and cancer. The present review summarizes and discusses evidence highlighting recent advances in our understanding on the role of ILPs as the link between insulin resistance and cancer and between immune deregulation and cancer in obesity, as well as those areas where there remains a paucity of data. It is anticipated that issues discussed in this paper will also recover new therapeutic targets that can assist in diagnostic screening and novel approaches to controlling tumor development.
authors.affiliation: Department of Animal Biology and Physiology, University of Yaoundé 1, PO Box 812, Yaoundé, Cameroon.
authors.forename: Sefirin
authors.initials: S
authors.lastname: Djiogue
authors.forename: Armel Hervé
authors.initials: AH
authors.lastname: Nwabo Kamdje
authors.forename: Lorella
authors.initials: L
authors.lastname: Vecchio
authors.forename: Maulilio John
authors.initials: MJ
authors.lastname: Kipanyula
authors.forename: Mohammed
authors.initials: M
authors.lastname: Farahna
authors.forename: Yousef
authors.initials: Y
authors.lastname: Aldebasi
authors.forename: Paul Faustin
authors.initials: PF
authors.lastname: Seke Etet
mesh_terms: D000818:Animals; D004734:Energy Metabolism; D006801:Humans; D007328:Insulin / Q000378:metabolism*; D007333:Insulin Resistance; D009369:Neoplasms / Q000209:etiology* / Q000378:metabolism / Q000473:pathology; D015398:Signal Transduction; D013002:Somatomedins / Q000378:metabolism*
chemical_list: D007328:Insulin; D013002:Somatomedins